Literature DB >> 14681305

The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes.

Martina Niksic1, Joan Slight, Jeremy R Sanford, Javier F Caceres, Nicholas D Hastie.   

Abstract

Mutations of the Wilms' tumour-1 (WT1) gene in humans can lead to childhood kidney cancer, life-threatening glomerular nephropathy and gonadal dysgenesis. The WT1 protein is normally expressed in the developing genitourinary tract, heart, spleen and adrenal glands and is crucial for their development, however it's function at the molecular level is yet to be fully understood. The protein is predominantly nuclear and there is evidence that the two different isoforms of WT1 (-KTS and +KTS) are involved in two different steps of gene expression control: transcription and RNA processing. In this study we report a novel property of WT1, namely that it shuttles between the nucleus and cytoplasm. Moreover, western blot analysis showed that between 10 and 50% of total cellular WT1 can be detected in the cytoplasm depending on the cell type. A significant proportion of cytoplasmic WT1 is in association with ribonucleoprotein particles (RNPs), which strengthens the idea of its involvement in RNA metabolism. Furthermore, we report that WT1 is associated with actively translating polysomes, extending even further the potential roles of WT1 and opening the possibility that it is involved in the regulation of translation. Interestingly, despite the functional differences between two of the WT1 isoforms (+/-KTS) within the nucleus, both isoforms share the shuttling property and are found in translating polysomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14681305     DOI: 10.1093/hmg/ddh040

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells.

Authors:  Murielle M Akpa; Diana Iglesias; LeeLee Chu; Antonin Thiébaut; Ida Jentoft; Leah Hammond; Elena Torban; Paul R Goodyer
Journal:  J Biol Chem       Date:  2015-12-10       Impact factor: 5.157

3.  Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin.

Authors:  Ofelia M Martínez-Estrada; Laura A Lettice; Abdelkader Essafi; Juan Antonio Guadix; Joan Slight; Víctor Velecela; Emma Hall; Judith Reichmann; Paul S Devenney; Peter Hohenstein; Naoki Hosen; Robert E Hill; Ramón Muñoz-Chapuli; Nicholas D Hastie
Journal:  Nat Genet       Date:  2009-12-20       Impact factor: 38.330

4.  WT1 Expression in Adult Granular Cell Tumor of the Vocal Cord and Tongue.

Authors:  Adriana Handra-Luca
Journal:  Head Neck Pathol       Date:  2015-07-11

5.  Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident Cells.

Authors:  Victor G Puelles; Rebecca N Douglas-Denton; Luise A Cullen-McEwen; Jinhua Li; Michael D Hughson; Wendy E Hoy; Peter G Kerr; John F Bertram
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

6.  WT1 regulates the development of the posterior taste field.

Authors:  Yankun Gao; Eneda Toska; Dane Denmon; Stefan G E Roberts; Kathryn F Medler
Journal:  Development       Date:  2014-05-06       Impact factor: 6.868

7.  Sex determination in the Squalius alburnoides complex: an initial characterization of sex cascade elements in the context of a hybrid polyploid genome.

Authors:  Irene Pala; Manfred Schartl; Sólveig Thorsteinsdóttir; Maria Manuela Coelho
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

8.  The Wilms' tumor suppressor protein WT1 is processed by the serine protease HtrA2/Omi.

Authors:  Jörg Hartkamp; Brian Carpenter; Stefan G E Roberts
Journal:  Mol Cell       Date:  2010-01-29       Impact factor: 17.970

9.  Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.

Authors:  Jennifer L Gregg; Kathleen E Brown; Eric M Mintz; Helen Piontkivska; Gail C Fraizer
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

10.  PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.

Authors:  Jean-François Michiels; Christophe Perrin; Nathalie Leccia; Daniela Massi; Paul Grimaldi; Nicole Wagner
Journal:  Pflugers Arch       Date:  2010-01-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.